Symptomatic treatment of colopathies, functional.

Oral: the contents of a sachet may be stirred in half a glass of water or mixed with a semi-liquid food such as boiled, mashed, etc.
< Br>
Administer preferably between meals or a little before

Adults: 3 sachets per day in average

Children

· Before 2 years: half a sachet 1 to 2 times a day.

· From 2 years to 5 years: half a sachet 2 to 3 times per day

· 5 to 10 years: 1 sachet 2 times a day.

Rectal canal: 1 to 3 enemas to be kept per day. For each enema: 1 to 3 sachets in 100 ml of lukewarm water.
Pharmacotherapeutic group OTHER INTESTINAL ADSORBENTS ATC code: A07BC05 (A: apparatus, digestive and metabolism)

The Beidellitic Montmorillonite enters the class of natural clays. Due to its lamellar structure, the fineness of its particles and its high viscosity, it perfectly and completely covers the digestive mucosa. In vitro, it activates factors VII and XII of coagulation and reduces hemorrhagic suffusions. Its adsorptive power is powerful, with respect to the various microbial toxins and it confers an important detoxifying power. BEDELIX has a very low swelling power and has no effect on the physiological intestinal transit. Chemically neutral, it is radiotransparent and does not modify the coloration of the stools.

No effect on the ability to drive and use machines has been reported.
Hypersensitivity to the active substance or to any of the excipients.

Stenosing affections of the tube, digestive

Although the dose of aluminum hydroxide is minimal, this should be taken into account in chronic dialysis patients (cases of encephalopathies having been described after extensive treatments and prolonged by aluminum hydroxide). >

It is known that the absorption of aluminum may be the cause of phosphorus depletion in the long term, but in recent clinical trials there has been no elevation of blood or urinary aluminum, Reported under treatment. The calcium phosphate tests are not modified.

This medicinal product contains glucose and is not recommended for use in patients with malabsorption syndrome of glucose and galactose.
Associations subject to precautions for use

Gastrointestinal topicals, anthrax and antacids, associated or not with alginates, decrease the digestive resorption of some others, medicines ingested simultaneously

As a precautionary measure, these topical or antacids should be taken at a distance:
+; Acetylsalicylic acid

+ Antihistamine antisecretory H2

+; Atenolol

+; Biphosphonates (oral)

+ Sulfo-sodium catioresin (reduction of the capacity of the resin to fix potassium, with risk of metabolic alkalosis in the insufficient, renal). >
Chloroquine

+; Cyclines

+ Digital;
+; Ethambutol

+; Iron

+; Fexofenadine

+; Fluor

+; Fluoroquinolones

+; Glucocorticoids except hydrocortisone in replacement therapy (described for prednisolone and dexamethasone)

+ Thyroid hormones

+; Indomethacin

+; Isoniazide

+; Ketoconazole (decrease in digestive absorption by elevation of gastric pH)

+; Lansoprazole

+; Lincosanides

+ Metoprolol

+ Phenothiazine neuroleptics

+ Penicillamine

+ Phosphorus

+; Propranolol

+; Sulpiride

Association to be taken into account

+; Ulipristal

Risk of decreasing the effect of ulipristal by decreasing its absorption

Not applicable.

No cases of overdose have been reported in adults. A very limited number of cases of overdosage have been reported in children. The associated symptoms were bezoar and vomiting.

Use with caution in pregnant or lactating women due to lack of clinical data.
Since the marketing of BEDELIX, the following undesirable effects have been reported (unknown frequency)
Skin and tissue disorders, subcutaneous

· Rash, angioedema, pruritus and urticaria.

Symptomatic treatment of colopathies, functional.